Corcept Investors Face April Deadline in Securities Fraud Class Action Over Drug Trial Data
Rosen Law Firm files securities fraud class action against Corcept Therapeutics, alleging misrepresentation of relacorilant drug trial data. Lead plaintiff deadline: April 21, 2026.
CORTMNDYHCXYHTGCsecurities class actionrelacorilant